Omega Pharma

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Omega Pharma N.V.
Naamloze vennootschap
Traded as EuronextOME
Industry Pharmaceuticals
Founded 1987
Headquarters Nazareth, Belgium
Key people
Marc Coucke (CEO), Lucas Laureys (Chairman)
Products Prescription-free medicines and healthcare products
Revenue €878.7 million (2010)[1]
€107.5 million (2010)[1]
Profit €69.5 million (2010)[1]
Total assets €1.443 billion (end 2010)[1]
Total equity €718.3 million (end 2010)[1]
Number of employees
2,130 (end 2010)[1]

Omega Pharma is a Belgian Pharmaceutical company, founded in 1987 by Marc Coucke (born 1965) and Yvan Vindevogel, both former Pharmacy students at the Ghent University.

The company was quoted at Euronext Brussels and used to be part of the BEL20 index till end 2011.


Main article: Arseus (company)

At the occasion of the annual shareholders meeting of June 6, 2006; Omega Pharma announced the name under which its Professional Health division will henceforward operate: Arseus. Simultaneously, the management team of Arseus was presented. The legal structure of the entities in this division has been largely prepared in the mean time, so that the project to make Arseus an autonomous company is on schedule. Arseus became effectively an independent entity via an IPO on October 5, 2007 and has been listed on NYSE Euronext Brussels and NYSE Euronext Amsterdam since then.


  1. ^ a b c d e f "Annual Report 2010". Omega Pharma. Retrieved 22 April 2011. [1]

External links[edit]

  1. ^ "Perrigo to buy Belgium's Omega Pharma for $3.11 billion". Thomson Reuters. Reuters.